{"id":"https://genegraph.clinicalgenome.org/r/b2327ba9-1b63-40bf-b2f4-e2bd8923858bv1.1","type":"EvidenceStrengthAssertion","dc:description":"MAN2C1 was first reported in relation to autosomal recessive congenital disorder of deglycosylation 2 in 2022 (Maia et al., PMID 35045343). Five variants (missense, frameshift, splice site) that have been reported in 4 probands in 1 publication (PMID 35045343) are included in this curation. Patients have a range of symptoms, including dysmorphic facies, impaired intellectual development, and brain anomalies. The disease mechanism appears to be biallelic loss of function. Heterozygous carriers are reportedly unaffected. As there are specific splice site and LOF variants present in GnomAD in homozygous state (including c.2303G>A and c.601-2A>G and 15-75364145-GTGTAC-G) there is a possibility of reduced penetrance for this condition. This gene-disease relationship is also supported by in vitro assays showing a deficiency in free oligosaccharide processing (PMIDs 35045343, 16848760) as well as a mouse model (PMID 24550399). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Congenital Disorder of Glycosylation GCEP on the meeting date November 7, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b2327ba9-1b63-40bf-b2f4-e2bd8923858b","GCISnapshot":"https://genegraph.clinicalgenome.org/r/45ab2f0c-af56-4fc0-8430-22d86e5bd8a3","calculatedEvidenceStrength":"Moderate","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/45ab2f0c-af56-4fc0-8430-22d86e5bd8a3_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-11-07T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/45ab2f0c-af56-4fc0-8430-22d86e5bd8a3_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-07-17T20:36:24.055Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45ab2f0c-af56-4fc0-8430-22d86e5bd8a3_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be310c73-a890-40e0-8076-8793a6772fa1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be310c73-a890-40e0-8076-8793a6772fa1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","rdfs:label":"Maia Individual 6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/b919e358-75c6-4c05-a9ee-1e40a78670fb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006715.4(MAN2C1):c.601-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7666924"}},{"id":"https://genegraph.clinicalgenome.org/r/2577c48e-7ca1-4138-aec8-e5a5cc2027c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006715.4(MAN2C1):c.2612G>C (p.Cys871Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7666148"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002463","obo:HP_0001249","obo:HP_0030220","obo:HP_0002126","obo:HP_0000347","obo:HP_0011729","obo:HP_0033725"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ace287d7-db58-4dbc-afa8-5ca5ba941d28_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","allele":{"id":"https://genegraph.clinicalgenome.org/r/b919e358-75c6-4c05-a9ee-1e40a78670fb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/a7967976-1616-47f4-87e5-febae0cf1dd9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","allele":{"id":"https://genegraph.clinicalgenome.org/r/2577c48e-7ca1-4138-aec8-e5a5cc2027c5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/ace287d7-db58-4dbc-afa8-5ca5ba941d28","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ace287d7-db58-4dbc-afa8-5ca5ba941d28_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a7967976-1616-47f4-87e5-febae0cf1dd9","type":"EvidenceLine","dc:description":"Reduced given that enzyme activity was increased.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7967976-1616-47f4-87e5-febae0cf1dd9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a7967976-1616-47f4-87e5-febae0cf1dd9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Enzyme activity in HEK293 cells was increased compared to wt (figure 5C).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/2fda39c4-f9eb-4f52-8685-344405377416_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2fda39c4-f9eb-4f52-8685-344405377416","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","rdfs:label":"Maia Individual 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b919e358-75c6-4c05-a9ee-1e40a78670fb"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"pelvicalyceal dilatation","phenotypes":["obo:HP_0012433","obo:HP_0000347","obo:HP_0000750","obo:HP_0001270","obo:HP_0000708"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4508f39d-a147-47df-844a-7d139ea3a666_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","allele":{"id":"https://genegraph.clinicalgenome.org/r/b919e358-75c6-4c05-a9ee-1e40a78670fb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}},{"id":"https://genegraph.clinicalgenome.org/r/4508f39d-a147-47df-844a-7d139ea3a666","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4508f39d-a147-47df-844a-7d139ea3a666_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/45ab2f0c-af56-4fc0-8430-22d86e5bd8a3_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1cdaa6b-7cd7-4475-8c6e-bfaf41f41d81_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations to count.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","rdfs:label":"Maia Family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/f1cdaa6b-7cd7-4475-8c6e-bfaf41f41d81","type":"Family","rdfs:label":"Maia Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/2fda39c4-f9eb-4f52-8685-344405377416"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0012433","obo:HP_0001270","obo:HP_0000347","obo:HP_0000750","obo:HP_0000708"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2fda39c4-f9eb-4f52-8685-344405377416"}},{"id":"https://genegraph.clinicalgenome.org/r/b1c859da-f5ac-42b7-809a-18d453604d12_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough individuals.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","rdfs:label":"Maia Family 2","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/b1c859da-f5ac-42b7-809a-18d453604d12","type":"Family","rdfs:label":"Maia Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/f938858e-83da-425b-aa38-f30cf24e4c1c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","rdfs:label":"Maia Individual 3","ageType":"AgeAtDiagnosis","ageUnit":"WeeksGestation","ageValue":28,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/2577c48e-7ca1-4138-aec8-e5a5cc2027c5"},{"id":"https://genegraph.clinicalgenome.org/r/82e04fbf-8d6d-4012-a8b4-8768db76856c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006715.4(MAN2C1):c.2733_2734del (p.His911GlnfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7666083"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002282","obo:HP_0002365","obo:HP_0011802","obo:HP_0002444","obo:HP_0002119","obo:HP_0000347","obo:HP_0001320","obo:HP_0007370"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8d69764e-1d73-4cf5-85ac-9aef162e58c8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","allele":{"id":"https://genegraph.clinicalgenome.org/r/82e04fbf-8d6d-4012-a8b4-8768db76856c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/2171d19d-210a-4b0b-9117-d52c29eabf64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","allele":{"id":"https://genegraph.clinicalgenome.org/r/2577c48e-7ca1-4138-aec8-e5a5cc2027c5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002282","obo:HP_0002444","obo:HP_0002119","obo:HP_0001320","obo:HP_0007370","obo:HP_0011802","obo:HP_0002365"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f938858e-83da-425b-aa38-f30cf24e4c1c"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f938858e-83da-425b-aa38-f30cf24e4c1c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f938858e-83da-425b-aa38-f30cf24e4c1c"},{"id":"https://genegraph.clinicalgenome.org/r/2171d19d-210a-4b0b-9117-d52c29eabf64","type":"EvidenceLine","dc:description":"Reduced given that enzyme activity increased.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2171d19d-210a-4b0b-9117-d52c29eabf64_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2171d19d-210a-4b0b-9117-d52c29eabf64_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Enzyme activity in HEK293 cells was increased compared to wt (figure 5C).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/8d69764e-1d73-4cf5-85ac-9aef162e58c8","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d69764e-1d73-4cf5-85ac-9aef162e58c8_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/05f5b242-1471-4ea0-8f4f-807d36a4139f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05f5b242-1471-4ea0-8f4f-807d36a4139f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","rdfs:label":"Maia Individual 5","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2484aa33-4fc3-492c-ba4f-63cb9623490d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006715.4(MAN2C1):c.607G>A (p.Gly203Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7666919"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000486","obo:HP_0002126","obo:HP_0000347","obo:HP_0001270","obo:HP_0000252","obo:HP_0001320","obo:HP_0002463","obo:HP_0001249","obo:HP_0002365","obo:HP_0032327"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7be62f69-4a0b-4d50-ba3f-49e7fba3ebfb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","allele":{"id":"https://genegraph.clinicalgenome.org/r/2484aa33-4fc3-492c-ba4f-63cb9623490d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/7be62f69-4a0b-4d50-ba3f-49e7fba3ebfb","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7be62f69-4a0b-4d50-ba3f-49e7fba3ebfb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/7be62f69-4a0b-4d50-ba3f-49e7fba3ebfb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Enzyme activity in HEK293 cells was moderately reduced compared to wt (figure 5C).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/45ab2f0c-af56-4fc0-8430-22d86e5bd8a3_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45ab2f0c-af56-4fc0-8430-22d86e5bd8a3_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7f9ea6a-d3d8-4ddf-be5f-89335ff5d91c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16624c68-1635-4cc0-8205-543519409c80","type":"Finding","dc:description":"The endoplasmic-reticulum-associated degradation of misfolded (glyco)proteins ensures that only functional, correctly folded proteins exit from the endoplasmic reticulum and that misfolded ones are degraded by the ubiquitin–proteasome system. During the degradation of misfolded glycoproteins, they are deglycosylated by the PNGase (peptide:N-glycanase). The free oligosaccharides released by PNGase are known to be further catabolized by a cytosolic α-mannosidase, although the gene encoding this enzyme has not been identified unequivocally. The findings in the present study demonstrate that an α-mannosidase, Man2C1, is involved in the processing of free oligosaccharides that are formed in the cytosol. Patients with variants in MAN2C1 show accumulation of free oligosaccharides, leading to neurodevelopmental phenotypes, consistent with another disorder of decglycosylation, NGLY1-CDDG.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16848760","rdfs:label":"Suzuki Biochemical Function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/45ab2f0c-af56-4fc0-8430-22d86e5bd8a3_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83e2469d-d812-4e65-b562-578abfdcb3ff","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/deb7bc72-6e59-4d8d-b135-166f40289c89","type":"FunctionalAlteration","dc:description":"The catabolism of free oligosaccharides (fOSs) is linked to the activity of MAN2C1, which cleaves mannose residues. The processing of fOSGn2 into FOSGn1 is delayed in individuals 1 and 2 compared to control.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","rdfs:label":"Maia Patient Cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/45ab2f0c-af56-4fc0-8430-22d86e5bd8a3_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cfac0e36-3da1-48f3-aa48-f8d5708cdc56","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/edf6572b-253c-472d-b685-7dbc030bcd20","type":"Finding","dc:description":"In MAN2C1-KO, while larger fOS species (M7 to M9Gn1) already predominate after the pulse (Figure 5F), a complete lack of fOS processing during the chase is observed, as no M5Gn1 species are found. In order to evaluate the requirement of MAN2C1 in oligosaccharides’ processing, the authors performed genetic complementation of WT-MAN2C1 in MAN2C1-KO HAP1 cells and we reanalyzed fOSs as before. Compared to MAN2C1-KO cells, fOS analysis after 2 h of chase in complemented MAN2C1-KO cells shows the processing of larger fOSs into M5Gn1 species (black peak). The functional rescue of fOS metabolism via complementation unambiguously demonstrates the involvement of MAN2C1 in this process (Figure 6C).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35045343","rdfs:label":"Maia HAP1 cells","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/85564705-1e0d-47b5-8051-b59eaf8611bc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84d9fa0c-aabb-4f4f-92b8-0f68c5ec50c0","type":"Finding","dc:description":"The accumulation of Man8–9GlcNAc oligosaccharides was recognized in the brain, heart, kidney, liver, lung, and spleen of KO mice. A quantitative analysis showed higher levels of fOS in the spleen and liver when compared with the other analyzed KO tissues (Fig. 4, A and B). The mice also showed histological changes in the CNS, such as neuronal and glial degeneration, vacuolization, and general lesions in the subcortical white matter, consistent with neurodevelopemtal changes in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24550399","rdfs:label":"Paciotti Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Moderate","sequence":10819,"specifiedBy":"GeneValidityCriteria10","strengthScore":10.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Q7omNVEPLZE","type":"GeneValidityProposition","disease":"obo:MONDO_0030770","gene":"hgnc:6827","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_45ab2f0c-af56-4fc0-8430-22d86e5bd8a3-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}